{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:56:40Z","timestamp":1791849400005,"version":"4.3.4"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10072-026-09337-1","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T03:30:18Z","timestamp":1787283018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the impacts of type 2 diabetes and metformin use on Parkinson\u2019s disease: Mendelian randomization analysis and a national cohort study"],"prefix":"10.1007","volume":"47","author":[{"given":"Li","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ancha","family":"Baranova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3204-8191","authenticated-orcid":false,"given":"Fuquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"11","key":"9337_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657\u2013673","journal-title":"Nat Rev Immunol"},{"issue":"10423","key":"9337_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C (2024) The epidemiology of Parkinson\u2019s disease. Lancet 403(10423):283\u2013292","journal-title":"Lancet"},{"issue":"12","key":"9337_CR3","doi-asserted-by":"publisher","first-page":"10216","DOI":"10.1007\/s12035-024-04197-2","volume":"61","author":"Y Wang","year":"2024","unstructured":"Wang Y, Shi X, Yin Y et al (2024) Association between neuroinflammation and Parkinson\u2019s disease: a comprehensive Mendelian randomization study. Mol Neurobiol 61(12):10216\u201310226","journal-title":"Mol Neurobiol"},{"key":"9337_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13020561","author":"AS Mai","year":"2024","unstructured":"Mai AS, Tan BJ, Sun QY, Tan EK (2024) Association between type 1 diabetes mellitus and Parkinson\u2019s disease: a Mendelian randomization study. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13020561","journal-title":"J Clin Med"},{"issue":"1","key":"9337_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13024-023-00694-5","volume":"18","author":"KC Paul","year":"2023","unstructured":"Paul KC, Zhang K, Walker DI et al (2023) Untargeted serum metabolomics reveals novel metabolite associations and disruptions in amino acid and lipid metabolism in Parkinson\u2019s disease. Mol Neurodegener 18(1):100","journal-title":"Mol Neurodegener"},{"key":"9337_CR6","unstructured":"Magliano DJ, Boyko EJ. IDF DIABETES ATLAS. 10th ed. Brussels; 2021"},{"issue":"2","key":"9337_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2025.104371","volume":"36","author":"W Sun","year":"2026","unstructured":"Sun W, Cao H, Liu D, Baranova A, Zhang X, Zhang F (2026) Insights into causal associations between type 2 diabetes and common human diseases: a phenotype-wide bi-directional Mendelian randomization analysis. Nutr Metab Cardiovasc Dis 36(2):104371","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"46","key":"9337_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040412","volume":"103","author":"Y Wei","year":"2024","unstructured":"Wei Y, Xu S, Wu Z, Zhang M, Bao M, He B (2024) Exploring the causal relationships between type 2 diabetes and neurological disorders using a Mendelian randomization strategy. Medicine (Baltimore) 103(46):e40412","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"9337_CR9","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1002\/mds.23855","volume":"26","author":"N Palacios","year":"2011","unstructured":"Palacios N, Gao X, McCullough ML et al (2011) Obesity, diabetes, and risk of Parkinson\u2019s disease. Mov Disord 26(12):2253\u20132259","journal-title":"Mov Disord"},{"issue":"1","key":"9337_CR10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1152\/physrev.00062.2017","volume":"99","author":"GA Dienel","year":"2019","unstructured":"Dienel GA (2019) Brain glucose metabolism: integration of energetics with function. Physiol Rev 99(1):949\u20131045","journal-title":"Physiol Rev"},{"key":"9337_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001370","author":"F Ping","year":"2020","unstructured":"Ping F, Jiang N, Li Y (2020) Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis. BMJ Open Diabetes Res Care. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001370","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"9337_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12035-025-05306-5","volume":"63","author":"M Zhao","year":"2025","unstructured":"Zhao M, Li T, Shen H, Baranova A, Chandhoke V, Zhang F (2025) Bidirectional causal associations between plasma metabolites and Parkinson\u2019s disease. Mol Neurobiol 63(1):30","journal-title":"Mol Neurobiol"},{"issue":"4","key":"9337_CR13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s11010-023-04771-7","volume":"479","author":"M Alrouji","year":"2024","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI et al (2024) Metformin role in Parkinson\u2019s disease: a double-sword effect. Mol Cell Biochem 479(4):975\u2013991","journal-title":"Mol Cell Biochem"},{"key":"9337_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.111155","volume":"136","author":"RD Ordovich-Clarkson","year":"2025","unstructured":"Ordovich-Clarkson RD, Jabbour M, Pelayo DA et al (2025) Comparing psilocybin to metformin as neuroprotective agents against Parkinson\u2019s dementia: a systematic review of evidence and efficacy. Prog Neuropsychopharmacol Biol Psychiatry 136:111155","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9337_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111212","volume":"403","author":"C Zhong","year":"2024","unstructured":"Zhong C, Wang C, Li W et al (2024) A derivative of honokiol HM568 has an anti-neuroinflammatory effect in Parkinson\u2019s disease. Chem Biol Interact 403:111212","journal-title":"Chem Biol Interact"},{"key":"9337_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.665075","volume":"12","author":"S Li","year":"2021","unstructured":"Li S, Zhang Q, Gao Y et al (2021) Serum folate, vitamin B12 levels, and systemic immune-inflammation index correlate with motor performance in Parkinson\u2019s disease: a cross-sectional study. Front Neurol 12:665075","journal-title":"Front Neurol"},{"issue":"6","key":"9337_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2025-102225","volume":"38","author":"L Fu","year":"2025","unstructured":"Fu L, Baranova A, Cao H, Zhang F (2025) Investigating the causal role of circulating metabolites in major depressive disorder. Gen Psychiatr 38(6):e102225","journal-title":"Gen Psychiatr"},{"issue":"4","key":"9337_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2024-101855","volume":"38","author":"S Shi","year":"2025","unstructured":"Shi S, Liu D, Baranova A, Cao H, Zhang F (2025) Investigating bidirectional causal relationships between gut microbiota and insomnia. Gen Psychiatr 38(4):e101855","journal-title":"Gen Psychiatr"},{"issue":"4","key":"9337_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.2174\/0115672026424248251130205128","volume":"22","author":"X Jiang","year":"2025","unstructured":"Jiang X, Xie F, Sun Y et al (2025) Causal association between cerebrospinal fluid metabolites and stroke: a Mendelian randomization study. Curr Neurovasc Res 22(4):296\u2013306","journal-title":"Curr Neurovasc Res"},{"issue":"1","key":"9337_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2174\/0115672026380807250530112524","volume":"22","author":"C Ren","year":"2025","unstructured":"Ren C, Gao Q, Li X et al (2025) Headache and intracranial aneurysm: a bidirectional Mendelian randomization study. Curr Neurovasc Res 22(1):40\u201352","journal-title":"Curr Neurovasc Res"},{"issue":"11","key":"9337_CR21","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1038\/s41588-021-00954-4","volume":"53","author":"L Jiang","year":"2021","unstructured":"Jiang L, Zheng Z, Fang H, Yang J (2021) A generalized linear mixed model association tool for biobank-scale data. Nat Genet 53(11):1616\u20131621","journal-title":"Nat Genet"},{"issue":"7944","key":"9337_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P et al (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944):508\u2013518","journal-title":"Nature"},{"key":"9337_CR23","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife. https:\/\/doi.org\/10.7554\/eLife.34408","journal-title":"Elife"},{"issue":"4","key":"9337_CR24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304\u2013314","journal-title":"Genet Epidemiol"},{"key":"9337_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-genom-083117-021731","volume":"19","author":"S Burgess","year":"2018","unstructured":"Burgess S, Foley CN, Zuber V (2018) Inferring causal relationships between risk factors and outcomes from genome-wide association study data. Annu Rev Genomics Hum Genet 19:303\u2013327","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"3","key":"9337_CR26","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/ije\/dyy258","volume":"48","author":"J Bowden","year":"2019","unstructured":"Bowden J, Del Greco MF, Minelli C et al (2019) Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption. Int J Epidemiol 48(3):728\u2013742","journal-title":"Int J Epidemiol"},{"key":"9337_CR27","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038984","author":"E Sanderson","year":"2021","unstructured":"Sanderson E (2021) Multivariable Mendelian randomization and mediation. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a038984","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"9337_CR28","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/jamia\/ocv063","volume":"23","author":"HJ Duggirala","year":"2016","unstructured":"Duggirala HJ, Tonning JM, Smith E et al (2016) Use of data mining at the Food and Drug Administration. J Am Med Inform Assoc 23(2):428\u2013434","journal-title":"J Am Med Inform Assoc"},{"key":"9337_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2024.107849","volume":"234","author":"M Cazzola","year":"2024","unstructured":"Cazzola M, Ora J, Calzetta L, Rogliani P, Matera MG (2024) Beta-blockers and asthma: surprising findings from the FAERS database. Respir Med 234:107849","journal-title":"Respir Med"},{"key":"9337_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1452300","volume":"15","author":"W Ye","year":"2024","unstructured":"Ye W, Ding Y, Li M, Tian Z, Wang S, Liu Z (2024) Safety assessment of sulfasalazine: a pharmacovigilance study based on FAERS database. Front Pharmacol 15:1452300","journal-title":"Front Pharmacol"},{"issue":"Pt 3","key":"9337_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.119095","volume":"338","author":"Y Wang","year":"2025","unstructured":"Wang Y, Gao P, Wu Z et al (2025) Exploring the therapeutic potential of Chinese herbs on comorbid type 2 diabetes mellitus and Parkinson\u2019s disease: a mechanistic study. J Ethnopharmacol 338(Pt 3):119095","journal-title":"J Ethnopharmacol"},{"key":"9337_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.111164","volume":"136","author":"A Baranova","year":"2025","unstructured":"Baranova A, Liu D, Sun W et al (2025) Antidepressants account for the causal effect of major depressive disorder on type 2 diabetes. Prog Neuropsychopharmacol Biol Psychiatry 136:111164","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9337_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjment-2023-300975","author":"H Cao","year":"2024","unstructured":"Cao H, Baranova A, Zhao Q, Zhang F (2024) Bidirectional associations between mental disorders, antidepressants and cardiovascular disease. BMJ Ment Health. https:\/\/doi.org\/10.1136\/bmjment-2023-300975","journal-title":"BMJ Ment Health"},{"key":"9337_CR34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jad.2024.05.122","volume":"359","author":"L Fu","year":"2024","unstructured":"Fu L, Baranova A, Cao H, Zhang F (2024) Exploring the causal effects of depression and antidepressants on COVID-19. J Affect Disord 359:350\u2013355","journal-title":"J Affect Disord"},{"issue":"1","key":"9337_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/mds.30039","volume":"40","author":"A Zagare","year":"2025","unstructured":"Zagare A, Hemedan A, Almeida C et al (2025) Insulin resistance is a modifying factor for Parkinson\u2019s disease. Mov Disord 40(1):67\u201376","journal-title":"Mov Disord"},{"key":"9337_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2023.110672","volume":"199","author":"C Dai","year":"2023","unstructured":"Dai C, Tan C, Zhao L et al (2023) Glucose metabolism impairment in Parkinson\u2019s disease. Brain Res Bull 199:110672","journal-title":"Brain Res Bull"},{"issue":"10","key":"9337_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107773","volume":"300","author":"Y Qiao","year":"2024","unstructured":"Qiao Y, Kou J, Tian Y et al (2024) Subcellular localization and function analysis of PINK1 mitron in PD progression: mitron modulates mitochondrial morphology to regulate neuronal death. J Biol Chem 300(10):107773","journal-title":"J Biol Chem"},{"key":"9337_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20081850","author":"R Bajracharya","year":"2019","unstructured":"Bajracharya R, Youngson NA, Ballard JWO (2019) Dietary macronutrient management to treat mitochondrial dysfunction in Parkinson\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20081850","journal-title":"Int J Mol Sci"},{"key":"9337_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.968268","volume":"13","author":"EK Rautenberg","year":"2022","unstructured":"Rautenberg EK, Hamzaoui Y, Coletta DK (2022) Mini-review: mitochondrial DNA methylation in type 2 diabetes and obesity. Front Endocrinol (Lausanne) 13:968268","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"9337_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1872214810999160628105549","volume":"10","author":"MR Ashraghi","year":"2016","unstructured":"Ashraghi MR, Pagano G, Polychronis S, Niccolini F, Politis M (2016) Parkinson\u2019s disease, diabetes and cognitive impairment. Recent Pat Endocr Metab Immune Drug Discov 10(1):11\u201321","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"issue":"6","key":"9337_CR41","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s11011-022-01029-x","volume":"37","author":"J Xiong","year":"2022","unstructured":"Xiong J, Deng I, Kelliny S, Lin L, Bobrovskaya L, Zhou XF (2022) Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice. Metab Brain Dis 37(6):1941\u20131957","journal-title":"Metab Brain Dis"},{"issue":"3","key":"9337_CR42","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1515\/hmbci-2022-0103","volume":"44","author":"MS Sater","year":"2023","unstructured":"Sater MS, AlDehaini DMB, Malalla ZHA, Ali ME, Giha HA (2023) Plasma IL-6, TREM1, uPAR, and IL6\/IL8 biomarkers increment further witnessing the chronic inflammation in type 2 diabetes. Horm Mol Biol Clin Investig 44(3):259\u2013269","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"10423","key":"9337_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH (2024) The pathogenesis of Parkinson\u2019s disease. Lancet 403(10423):293\u2013304","journal-title":"Lancet"},{"issue":"6","key":"9337_CR44","first-page":"32","volume":"21","author":"S De","year":"2025","unstructured":"De S, Banerjee S, Rakshit P, Banerjee S, Kumar SKA (2025) Unraveling the ties: type 2 diabetes and Parkinson\u2019s disease - a nano-based targeted drug delivery approach. Curr Diabetes Rev 21(6):32\u201358","journal-title":"Curr Diabetes Rev"},{"issue":"6","key":"9337_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11892-021-01385-5","volume":"21","author":"S Cataldi","year":"2021","unstructured":"Cataldi S, Costa V, Ciccodicola A, Aprile M (2021) PPARgamma and diabetes: beyond the genome and towards personalized medicine. Curr Diab Rep 21(6):18","journal-title":"Curr Diab Rep"},{"key":"9337_CR46","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.2147\/DMSO.S429825","volume":"16","author":"YK Zhao","year":"2023","unstructured":"Zhao YK, Zhu XD, Liu R, Yang X, Liang YL, Wang Y (2023) The role of PPARgamma gene polymorphisms, gut microbiota in type 2 diabetes: current progress and future prospects. Diabetes Metab Syndr Obes 16:3557\u20133566","journal-title":"Diabetes Metab Syndr Obes"},{"key":"9337_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20205055","author":"HS Cheng","year":"2019","unstructured":"Cheng HS, Tan WR, Low ZS, Marvalim C, Lee JYH, Tan NS (2019) Exploration and development of PPAR modulators in health and disease: an update of clinical evidence. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20205055","journal-title":"Int J Mol Sci"},{"issue":"6","key":"9337_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002314","volume":"14","author":"AJ Noyce","year":"2017","unstructured":"Noyce AJ, Kia DA, Hemani G et al (2017) Estimating the causal influence of body mass index on risk of Parkinson disease: a Mendelian randomisation study. PLoS Med 14(6):e1002314","journal-title":"PLoS Med"},{"issue":"11","key":"9337_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70132","volume":"30","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Liu D, Baranova A, Cao H, Zhang F (2024) Novel insights into the causal effects and shared genetics between body fat and Parkinson disease. CNS Neurosci Ther 30(11):e70132","journal-title":"CNS Neurosci Ther"},{"key":"9337_CR50","doi-asserted-by":"crossref","unstructured":"Domenighetti C, Sugier PE, Ashok Kumar Sreelatha A et al (2024) Association of body mass index and parkinson disease: a bidirectional mendelian randomization study. Neurology 103(3): e209620","DOI":"10.1212\/WNL.0000000000209620"},{"key":"9337_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.parkreldis.2020.06.015","volume":"77","author":"VW Yong","year":"2020","unstructured":"Yong VW, Tan YJ, Ng YD et al (2020) Progressive and accelerated weight and body fat loss in Parkinson\u2019s disease: a three-year prospective longitudinal study. Parkinsonism Relat Disord 77:28\u201335","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"9337_CR52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s40520-019-01166-x","volume":"32","author":"MS Pisciotta","year":"2020","unstructured":"Pisciotta MS, Fusco D, Grande G et al (2020) Untangling the relationship between fat distribution, nutritional status and Parkinson\u2019s disease severity. Aging Clin Exp Res 32(1):77\u201384","journal-title":"Aging Clin Exp Res"},{"key":"9337_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2023.102462","volume":"226","author":"L Meng","year":"2023","unstructured":"Meng L, Li Y, Liu C et al (2023) Islet amyloid polypeptide triggers alpha-synuclein pathology in Parkinson\u2019s disease. Prog Neurobiol 226:102462","journal-title":"Prog Neurobiol"},{"issue":"9","key":"9337_CR54","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1080\/15548627.2020.1774149","volume":"16","author":"I Choi","year":"2020","unstructured":"Choi I, Seegobin SP, Liang D, Yue Z (2020) Synucleinphagy: a microglial \u201ccommunity cleanup program\u201d for neuroprotection. Autophagy 16(9):1718\u20131720","journal-title":"Autophagy"},{"issue":"44","key":"9337_CR55","doi-asserted-by":"publisher","first-page":"12473","DOI":"10.1073\/pnas.1610371113","volume":"113","author":"I Horvath","year":"2016","unstructured":"Horvath I, Wittung-Stafshede P (2016) Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson\u2019s disease. Proc Natl Acad Sci U S A 113(44):12473\u201312477","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9337_CR56","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00441-022-03636-7","volume":"389","author":"PY Thimmappa","year":"2022","unstructured":"Thimmappa PY, Nair AS, Najar MA et al (2022) Quantitative phosphoproteomics reveals diverse stimuli activate distinct signaling pathways during neutrophil activation. Cell Tissue Res 389(2):241\u2013257","journal-title":"Cell Tissue Res"},{"issue":"3","key":"9337_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213527","volume":"14","author":"T Silzer","year":"2019","unstructured":"Silzer T, Barber R, Sun J et al (2019) Circulating mitochondrial DNA: new indices of type 2 diabetes-related cognitive impairment in Mexican Americans. PLoS ONE 14(3):e0213527","journal-title":"PLoS ONE"},{"key":"9337_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111661","author":"V Bova","year":"2024","unstructured":"Bova V, Mannino D, Capra AP et al (2024) CK and LRRK2 involvement in neurodegenerative diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252111661","journal-title":"Int J Mol Sci"},{"key":"9337_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106728","volume":"202","author":"JF Tengberg","year":"2024","unstructured":"Tengberg JF, Russo F, Benned-Jensen T, Nielsen J (2024) LRRK2 and RAB8A regulate cell death after lysosomal damage in macrophages through cholesterol-related pathways. Neurobiol Dis 202:106728","journal-title":"Neurobiol Dis"},{"key":"9337_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010398","author":"F Agostini","year":"2021","unstructured":"Agostini F, Masato A, Bubacco L, Bisaglia M (2021) Metformin repurposing for Parkinson disease therapy: opportunities and challenges. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23010398","journal-title":"Int J Mol Sci"},{"key":"9337_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.678649","volume":"12","author":"X Qin","year":"2021","unstructured":"Qin X, Zhang X, Li P et al (2021) Association between diabetes medications and the risk of Parkinson\u2019s disease: a systematic review and meta-analysis. Front Neurol 12:678649","journal-title":"Front Neurol"},{"issue":"6","key":"9337_CR62","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.parkreldis.2012.03.010","volume":"18","author":"ML Wahlqvist","year":"2012","unstructured":"Wahlqvist ML, Lee MS, Hsu CC, Chuang SY, Lee JT, Tsai HN (2012) Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson\u2019s disease occurring with Type 2 diabetes in a Taiwanese population cohort. Parkinsonism Relat Disord 18(6):753\u2013758","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"9337_CR63","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00406-025-02039-3","volume":"275","author":"Q Zhou","year":"2025","unstructured":"Zhou Q, Du Z, Lu R, Shen Y, Jiang Y, Zhu H (2025) Genetic insights into the effect of Metformin on psychiatry disorders. Eur Arch Psychiatry Clin Neurosci 275(5):1465\u20131476","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"9337_CR64","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.mehy.2017.06.001","volume":"104","author":"K Maniar","year":"2017","unstructured":"Maniar K, Moideen A, Bhattacharyya R, Banerjee D (2017) Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: a hypothesis. Med Hypotheses 104:117\u2013120","journal-title":"Med Hypotheses"},{"issue":"3","key":"9337_CR65","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12020-018-1717-y","volume":"62","author":"HH Ning","year":"2018","unstructured":"Ning HH, Le J, Wang Q et al (2018) The effects of metformin on simple obesity: a meta-analysis. Endocr Res 62(3):528\u2013534","journal-title":"Endocr Res"},{"key":"9337_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14050946","author":"KH Huang","year":"2022","unstructured":"Huang KH, Chang YL, Gau SY, Tsai TH, Lee CY (2022) Dose-response association of metformin with Parkinson\u2019s disease odds in type 2 diabetes mellitus. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14050946","journal-title":"Pharmaceutics"},{"key":"9337_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2015.12.012","volume":"301","author":"JS Allard","year":"2016","unstructured":"Allard JS, Perez EJ, Fukui K, Carpenter P, Ingram DK, de Cabo R (2016) Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL\/6J mice. Behav Brain Res 301:1\u20139","journal-title":"Behav Brain Res"},{"key":"9337_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154308","volume":"104","author":"S Yan","year":"2022","unstructured":"Yan S, Lu W, Zhou J et al (2022) Aqueous extract of Scrophularia ningpoensis improves insulin sensitivity through AMPK-mediated inhibition of the NLRP3 inflammasome. Phytomedicine 104:154308","journal-title":"Phytomedicine"},{"key":"9337_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/diseases12090226","author":"AV Poznyak","year":"2024","unstructured":"Poznyak AV, Orekhov NA, Churov AV et al (2024) Mitochondrial dysfunction in systemic lupus erythematosus: insights and therapeutic potential. Diseases. https:\/\/doi.org\/10.3390\/diseases12090226","journal-title":"Diseases"},{"issue":"2","key":"9337_CR70","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3233\/JPD-171296","volume":"8","author":"DW Curry","year":"2018","unstructured":"Curry DW, Stutz B, Andrews ZB, Elsworth JD (2018) Targeting AMPK signaling as a neuroprotective strategy in Parkinson\u2019s disease. J Parkinsons Dis 8(2):161\u2013181","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"9337_CR71","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.neurobiolaging.2012.11.001","volume":"34","author":"P Jiang","year":"2013","unstructured":"Jiang P, Gan M, Ebrahim AS, Castanedes-Casey M, Dickson DW, Yen SH (2013) Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of alpha-synuclein oligomers and decrease of neurites. Neurobiol Aging 34(5):1504\u20131515","journal-title":"Neurobiol Aging"},{"issue":"1","key":"9337_CR72","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuron.2013.02.003","volume":"78","author":"G Mairet-Coello","year":"2013","unstructured":"Mairet-Coello G, Courchet J, Pieraut S, Courchet V, Maximov A, Polleux F (2013) The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Abeta oligomers through Tau phosphorylation. Neuron 78(1):94\u2013108","journal-title":"Neuron"},{"issue":"4","key":"9337_CR73","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2337\/dc06-2011","volume":"30","author":"G Hu","year":"2007","unstructured":"Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J (2007) Type 2 diabetes and the risk of Parkinson\u2019s disease. Diabetes Care 30(4):842\u2013847","journal-title":"Diabetes Care"},{"issue":"8","key":"9337_CR74","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1080\/14740338.2023.2278700","volume":"23","author":"J Li","year":"2024","unstructured":"Li J, Wang Y, Yang X, Zhu H, Jiang Z (2024) Drug-induced hypoglycemia: a disproportionality analysis of the FAERS database. Expert Opin Drug Saf 23(8):1061\u20131067","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"9337_CR75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/pds.4337","volume":"27","author":"CE Leonard","year":"2018","unstructured":"Leonard CE, Han X, Brensinger CM et al (2018) Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: a retrospective cohort study. Pharmacoepidemiol Drug Saf 27(1):9\u201318","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"9337_CR76","doi-asserted-by":"crossref","unstructured":"Rodrigues Vilela V, de Castro Ruiz Marques A, Schamber CR, Bazotte RB (2014) Hypoglycemia induced by insulin as a triggering factor of cognitive deficit in diabetic children. Sci World J 2014: 616534","DOI":"10.1155\/2014\/616534"},{"issue":"1","key":"9337_CR77","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1423-0127-17-7","volume":"17","author":"S Antony","year":"2010","unstructured":"Antony S, Peeyush Kumar T, Mathew J, Anju TR, Paulose CS (2010) Hypoglycemia induced changes in cholinergic receptor expression in the cerebellum of diabetic rats. J Biomed Sci 17(1):7","journal-title":"J Biomed Sci"},{"key":"9337_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/cells13171433","author":"M Toppila","year":"2024","unstructured":"Toppila M, Ranta-Aho S, Kaarniranta K, Hytti M, Kauppinen A (2024) Metformin alleviates inflammation and induces mitophagy in human retinal pigment epithelium cells suffering from mitochondrial damage. Cells. https:\/\/doi.org\/10.3390\/cells13171433","journal-title":"Cells"},{"key":"9337_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00440","volume":"12","author":"K Tayara","year":"2018","unstructured":"Tayara K, Espinosa-Oliva AM, Garcia-Dominguez I et al (2018) Divergent effects of metformin on an inflammatory model of Parkinson\u2019s disease. Front Cell Neurosci 12:440","journal-title":"Front Cell Neurosci"},{"key":"9337_CR80","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.taap.2016.03.004","volume":"298","author":"AA Ismaiel","year":"2016","unstructured":"Ismaiel AA, Espinosa-Oliva AM, Santiago M et al (2016) Metformin, besides exhibiting strong in vivo anti-inflammatory properties, increases mptp-induced damage to the nigrostriatal dopaminergic system. Toxicol Appl Pharmacol 298:19\u201330","journal-title":"Toxicol Appl Pharmacol"},{"key":"9337_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2024.111963","volume":"221","author":"ZZ Yu","year":"2024","unstructured":"Yu ZZ, Tu JJ, Ou ML et al (2024) A mechanistic analysis of metformin\u2019s biphasic effects on lifespan and healthspan in C. elegans: elixir in youth, poison in elder. Mech Ageing Dev 221:111963","journal-title":"Mech Ageing Dev"},{"issue":"11","key":"9337_CR82","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/s42255-020-00307-1","volume":"2","author":"L Espada","year":"2020","unstructured":"Espada L, Dakhovnik A, Chaudhari P et al (2020) Loss of metabolic plasticity underlies metformin toxicity in aged Caenorhabditis elegans. Nat Metab 2(11):1316\u20131331","journal-title":"Nat Metab"},{"issue":"1","key":"9337_CR83","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41398-024-02755-9","volume":"14","author":"SY Cho","year":"2024","unstructured":"Cho SY, Kim EW, Park SJ et al (2024) Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer\u2019s model mice. Transl Psychiatry 14(1):34","journal-title":"Transl Psychiatry"},{"issue":"1","key":"9337_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07294-5","volume":"23","author":"P Nie","year":"2025","unstructured":"Nie P, Yao B, Zhang Z et al (2025) Metformin protects against cyclophosphamide-induced ovarian fibrosis by MIF\/CD74-mediated macrophage polarization. J Transl Med 23(1):1273","journal-title":"J Transl Med"},{"issue":"1","key":"9337_CR85","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12967-025-06357-x","volume":"23","author":"Y Hu","year":"2025","unstructured":"Hu Y, Lu S, Xue C et al (2025) Exploring the protective effect of metformin against sarcopenia: insights from cohort studies and genetics. J Transl Med 23(1):356","journal-title":"J Transl Med"},{"issue":"1","key":"9337_CR86","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12967-024-06061-2","volume":"23","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Xue F (2025) Unlocking new potential: the evolving landscape of metformin repurposing trials. J Transl Med 23(1):24","journal-title":"J Transl Med"},{"issue":"2","key":"9337_CR87","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10787-023-01192-2","volume":"31","author":"M Alrouji","year":"2023","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Saad HM, Batiha GE (2023) A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson\u2019s disease: beneficial or detrimental effects. Inflammopharmacology 31(2):673\u2013688","journal-title":"Inflammopharmacology"},{"issue":"1","key":"9337_CR88","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11357-019-00146-3","volume":"42","author":"K Chaudhari","year":"2020","unstructured":"Chaudhari K, Reynolds CD, Yang SH (2020) Metformin and cognition from the perspectives of sex, age, and disease. Geroscience 42(1):97\u2013116","journal-title":"Geroscience"},{"issue":"1","key":"9337_CR89","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14336\/AD.2016.1010","volume":"8","author":"N Thangthaeng","year":"2017","unstructured":"Thangthaeng N, Rutledge M, Wong JM, Vann PH, Forster MJ, Sumien N (2017) Metformin impairs spatial memory and visual acuity in old male mice. Aging Dis 8(1):17\u201330","journal-title":"Aging Dis"},{"issue":"5","key":"9337_CR90","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.14283\/jpad.2024.148","volume":"11","author":"D Liu","year":"2024","unstructured":"Liu D, Baranova A, Zhang F (2024) Evaluating the causal effect of type 2 diabetes on Alzheimer\u2019s disease using large-scale genetic data. J Prev Alzheimers Dis 11(5):1280\u20131282","journal-title":"J Prev Alzheimers Dis"},{"issue":"6","key":"9337_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100129","volume":"12","author":"D Liu","year":"2025","unstructured":"Liu D, Cao H, Baranova A, Xu C, Zhang F (2025) Opposite causal effects of type 2 diabetes and metformin on Alzheimer\u2019s disease. J Prev Alzheimers Dis 12(6):100129","journal-title":"J Prev Alzheimers Dis"},{"key":"9337_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.111128","volume":"135","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Fei L, Duan Y (2024) Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study. Prog Neuropsychopharmacol Biol Psychiatry 135:111128","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9337_CR93","doi-asserted-by":"publisher","first-page":"1323057","DOI":"10.3389\/fdsfr.2023.1323057","volume":"3","author":"PM Cutroneo","year":"2023","unstructured":"Cutroneo PM, Sartori D, Tuccori M et al (2023) Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems. Front Drug Saf Regul 3:1323057","journal-title":"Front Drug Saf Regul"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09337-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09337-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09337-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:34:00Z","timestamp":1791848040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09337-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":93,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["9337"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09337-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"23 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval had been granted for each of the original GWAS studies. As our research only reanalyzed publicly released aggregated summary statistics, separate ethical approval was not required for the present work.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"726"}}